Evaluation of antibacterial activities of three commonly used antibiotics produced by different manufactures on female urinary tract infection uropathogens in Kalar city.
Health professional staff often claims information about trying to differentiate the used antibiotics based on the manufacturers that produce the drug, which may lead to a differentiation in the prescribing of the antibiotics by a physician. Numerous antibiotics produced by different manufactures, u...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Erbil Polytechnic University
2023-09-01
|
| Series: | Polytechnic Journal |
| Subjects: | |
| Online Access: | https://polytechnic-journal.epu.edu.iq/home/vol12/iss1/2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Health professional staff often claims information about trying to differentiate the used antibiotics based
on the manufacturers that produce the drug, which may lead to a differentiation in the prescribing of
the antibiotics by a physician. Numerous antibiotics produced by different manufactures, under different
brands names are available in pharmacies for urinary tract infection (UTI) treatment; this study
proceeds to find out and evaluates antibacterial activities of three most used antibiotics, produced by
different antibiotic producers on uropathogens in Kalar city. Kirby–Bauer disk diffusion method is
employed to assess antibacterial effectiveness of Amikacin (Ak), Levoflaxocilin (Lv) and Nitrofuratoin
(Nr) against reference strains of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus
saprophyticus and clinically isolated uropathogens (Escherichia coli, Pseudomonas aeruginosa,
Staphylococcus saprophyticus, Proteus vulgaris, and Klebsiella pneumoniae). Inhibition zones (IZ) were
determined in millimeter unit to show the activity of the antibiotics. It has been found that the activity
of all brands on sensitive bacterial strains were in the preferred range and surpassed the threshold of
(IZ) determined by Clinical Laboratories Standards Institute (CLSI) guide. The lack of significant
differences among most tested brands for each antibiotic, support this idea. |
|---|---|
| ISSN: | 2707-7799 |